SCLX Insider Trading
Insider Ownership Percentage: 7.65%
Insider Buying (Last 12 Months): $230,554.96
Insider Selling (Last 12 Months): $0.00
Scilex Share Price & Price History
Current Price: $0.30
Price Change: ▲ Price Increase of +0.0124 (4.34%)
As of 03/14/2025 05:00 PM ET
Scilex Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 12/18/2024 | Jaisim Shah | Insider | Buy | 30,000 | $0.46 | $13,800.00 | 139,333 |  |
| 10/31/2024 | Henry Ji | Insider | Buy | 8,888 | $0.94 | $8,354.72 | 320,161 | |
| 10/29/2024 | Jaisim Shah | Insider | Buy | 32,000 | $0.99 | $31,680.00 | 109,333 | |
| 10/17/2024 | Yue Alexander Wu | Director | Buy | 20,000 | $0.95 | $19,000.00 | 25,000 | |
| 10/16/2024 | Jaisim Shah | Insider | Buy | 30,000 | $0.99 | $29,700.00 | 77,333 | |
| 10/16/2024 | Stephen Hoi Ma | CFO | Buy | 6,700 | $0.97 | $6,499.00 | 22,840 | |
| 5/17/2024 | Jay Chun | Director | Buy | 57,500 | $0.90 | $51,750.00 | 102,500 | |
| 5/16/2024 | Jaisim Shah | Insider | Buy | 83,061 | $0.84 | $69,771.24 | 98,943 | |
Scilex Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 2/17/2025 | Janus Henderson Group PLC | 687,547 | $0.29M | 0.0% | +28.7% | 0.283% |  |
| 2/14/2025 | RA Capital Management L.P. | 1,036,218 | $0.44M | 0.0% | +296.7% | 0.426% | |
| 2/14/2025 | Jane Street Group LLC | 321,480 | $0.14M | 0.0% | +965.8% | 0.132% | |
| 2/14/2025 | Northern Trust Corp | 1,273,968 | $0.54M | 0.0% | +64.0% | 0.524% | |
| 2/12/2025 | Geode Capital Management LLC | 1,248,689 | $0.53M | 0.0% | -3.6% | 0.513% | |
| 2/12/2025 | Norges Bank | 477,619 | $0.20M | 0.0% | N/A | 0.196% | |
| 1/23/2025 | Donald L. Hagan LLC | 173,292 | $74K | 0.0% | +32.5% | 0.090% | |
| 11/15/2024 | XTX Topco Ltd | 86,335 | $80K | 0.0% | -18.1% | 0.045% | |
| 11/15/2024 | Jane Street Group LLC | 30,164 | $28K | 0.0% | -89.1% | 0.016% | |
| 11/15/2024 | State Street Corp | 7,484,310 | $6.92M | 0.0% | +0.7% | 3.902% | |
| 11/15/2024 | Janus Henderson Group PLC | 534,302 | $0.49M | 0.0% | +3.5% | 0.279% | |
| 10/31/2024 | Donald L. Hagan LLC | 130,792 | $0.12M | 0.1% | +15.4% | 0.068% | |
| 8/15/2024 | The Manufacturers Life Insurance Company | 12,935 | $25K | 0.0% | N/A | 0.007% | |
| 8/15/2024 | Armistice Capital LLC | 11,950,000 | $23.06M | 0.3% | N/A | 6.595% | |
| 8/12/2024 | XTX Topco Ltd | 105,431 | $0.20M | 0.0% | +321.4% | 0.058% | |
| 7/26/2024 | Bank of New York Mellon Corp | 15,815 | $31K | 0.0% | N/A | 0.009% | |
| 7/19/2024 | Donald L. Hagan LLC | 113,292 | $0.22M | 0.1% | +59.5% | 0.063% | |
| 5/10/2024 | Vanguard Group Inc. | 3,988,265 | $6.34M | 0.0% | +1.4% | 2.400% | |
| 4/17/2024 | Cannon Global Investment Management LLC | 25,000 | $40K | 0.1% | N/A | 0.015% | |
| 4/9/2024 | Collective Family Office LLC | 21,950 | $35K | 0.0% | +68.4% | 0.013% | |
| 2/13/2024 | Tower Research Capital LLC TRC | 20,595 | $42K | 0.0% | -82.7% | 0.013% | |
| 2/12/2024 | Focus Financial Network Inc. ADV | 28,257 | $58K | 0.0% | N/A | 0.018% | |
| 2/6/2024 | Apollon Wealth Management LLC | 36,100 | $74K | 0.0% | -27.8% | 0.023% | |
| 1/19/2024 | Donald L. Hagan LLC | 52,343 | $0.11M | 0.1% | +49.1% | 0.033% | |
| 12/7/2023 | Hudson Bay Capital Management LP | 474,683 | $0.67M | 0.0% | N/A | 0.301% | |
| 10/24/2023 | Bank of New York Mellon Corp | 48,459 | $68K | 0.0% | N/A | 0.032% | |
| 10/11/2023 | Donald L. Hagan LLC | 35,098 | $49K | 0.0% | +39.8% | 0.023% | |
| 8/14/2023 | Casdin Capital LLC | 23,512 | $0.13M | 0.0% | N/A | 0.016% | |
| 8/11/2023 | Deuterium Capital Management LLC | 23,994 | $96K | 0.1% | +25.8% | 0.016% | |
| 8/10/2023 | Ground Swell Capital LLC | 12,085 | $67K | 0.2% | N/A | 0.008% | |
| 8/7/2023 | Wolverine Asset Management LLC | 8,224 | $46K | 0.0% | N/A | 0.006% | |
| 7/17/2023 | Donald L. Hagan LLC | 25,098 | $0.14M | 0.1% | +66.2% | 0.017% | |
| 7/17/2023 | GoalVest Advisory LLC | 7,279 | $41K | 0.0% | N/A | 0.005% | |
| 6/14/2023 | State Board of Administration of Florida Retirement System | 14,219 | $0.12M | 0.0% | N/A | 0.010% | |
| 5/11/2023 | Citigroup Inc. | 239,130 | $1.96M | 0.0% | N/A | 0.164% | |
| 5/11/2023 | E Fund Management Co. Ltd. | 31,431 | $0.26M | 0.0% | N/A | 0.022% | |
| 5/9/2023 | Tower Research Capital LLC TRC | 10,538 | $86K | 0.0% | +1,159.0% | 0.007% | |
| 5/9/2023 | California State Teachers Retirement System | 81,066 | $0.67M | 0.0% | N/A | 0.056% | |
| 5/9/2023 | US Bancorp DE | 4,512 | $37K | 0.0% | N/A | 0.003% | |
| 5/8/2023 | New York Life Investment Management LLC | 34,109 | $0.28M | 0.0% | N/A | 0.023% | |
| 5/8/2023 | Public Employees Retirement Association of Colorado | 4,709 | $39K | 0.0% | N/A | 0.003% | |
| 5/8/2023 | Zurcher Kantonalbank Zurich Cantonalbank | 8,554 | $70K | 0.0% | N/A | 0.006% | |
| 5/5/2023 | Mayo Clinic | 42,303 | $0.35M | 0.3% | N/A | 0.029% | |
| 5/2/2023 | Amalgamated Bank | 8,654 | $71K | 0.0% | N/A | 0.006% | |
| 4/28/2023 | Handelsbanken Fonder AB | 11,168 | $92K | 0.0% | N/A | 0.008% | |
| 4/27/2023 | Arizona State Retirement System | 17,904 | $0.15M | 0.0% | N/A | 0.012% | |
| 4/18/2023 | Donald L. Hagan LLC | 15,098 | $0.12M | 0.1% | N/A | 0.010% | |
| 4/18/2023 | ETF Managers Group LLC | 16,589 | $0.14M | 0.0% | N/A | 0.011% | |
| 4/14/2023 | Raymond James Financial Services Advisors Inc. | 18,409 | $0.15M | 0.0% | N/A | 0.013% | |
| 4/14/2023 | Raymond James & Associates | 31,303 | $0.26M | 0.0% | N/A | 0.021% | |
| 4/11/2023 | Asset Management Resources LLC | 19,459 | $0.16M | 0.1% | N/A | 0.013% | |
Data available starting January 2016
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California.
Read More on Scilex
Volume
925,610 shs
Average Volume
1,409,725 shs
Market Capitalization
$72.56 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
1.15
Who are the company insiders with the largest holdings of Scilex?
Who are the major institutional investors of Scilex?
Which major investors are selling Scilex stock?
Within the last quarter, SCLX stock was sold by these institutional investors:
- Citadel Advisors LLC
- Geode Capital Management LLC
Which major investors are buying Scilex stock?
During the previous quarter, SCLX stock was acquired by institutional investors including:
- RA Capital Management L.P.
- Northern Trust Corp
- Norges Bank
- Jane Street Group LLC
- Janus Henderson Group PLC
- Group One Trading LLC
- Donald L. Hagan LLC
Within the last year, these company insiders have bought Scilex stock:
- Henry Ji (Insider)
- Jaisim Shah (Insider)
- Jay Chun (Director)
- Yue Alexander Wu (Director)
- Stephen Hoi Ma (CFO)
Learn More investors buying Scilex stock.
